Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients. - Milligan C; Atassi N; Babu S; Barohn RJ; Caress JB; Cudkowicz ME; Evora A; Hawkins GA; Wosiski-Kuhn M; Macklin EA; Shefner JM; Simmons Z; et al. (Muscle & nerve, 2021)